Mechanism of splenic immunosuppression during sepsis: Key role of Kupffer cell mediators

Journal of Trauma - Injury, Infection and Critical Care

Volumn 42, Issue 5, 1997, Pages 882-888

  Ayala, Alfred ^a,d   O'Neill, Patrick J ^c   Uebele, Stacey A ^b   Herdon, Crystal D ^b   Chaudry, Irshad H ^a  

^a BROWN UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

CLP; Kupffer cells; Lymphocyte dysfunction; Lymphokines; Sepsis; Splenocyte

Indexed keywords

GADOLINIUM CHLORIDE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL FUNCTION; CELL PROTECTION; CONFERENCE PAPER; DISEASE ASSOCIATION; HOST RESISTANCE; IMMUNOSUPPRESSIVE TREATMENT; KUPFFER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL;

EID: 0030910264     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199705000-00019     Document Type: Conference Paper

References (39)

1. Mannick JA. Trauma, sepsis and immune defects. In: Faist E, Meakins JL, Schildberg FW, eds. Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin: Springer-Verlag; 1993:15-21.
2. Baue AE. Multiple Organ Failure: Patient Care and Prevention. St Louis: Mosby: 1990:336-363.
3. Ayala A, Knotts JB, Ertel W, et al. Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch Surg. 1993;128:89.
4. Ayala A, Perrin MM, Kisala JM, et al. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6, and TNF). Circ Shock. 1992;36:191.
5. Ayala A, Kisala JM, Felt JA, et al. Does endotoxin tolerance prevent the release of inflammatory monokines (IL-1, IL-6, or TNF) during sepsis? Arch Surg. 1992; 127:191.
6. Chaudry IH, Ayala A, Singh G, et al. Rodent models of endotoxemia and sepsis. In: Schlag G, Redl H, eds. Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag; 1993:1048-1059.
7. Callery MP, Kamei T, Flye W. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990;125:36.
8. Ogle CK, Wu JZ, Mao JX, et al. Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation. 1994; 18:511.
9. O'Neill PJ, Ayala A, Wang P, et al. Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock. 1994;1:43.
10. Bankey PE, Prager M, Geldon D, et al. Acute-phase hepatocytes regulate liver sinusoidal cell mediator production. Arch Surg. 1994;129:1166.
11. Ayala A, Perrin MM, Wang P, et al. Sepsis induces an early increased spontaneous release of the hepatocellular stimulatory factor (IL-6) by Kupffer cells in both endotoxin tolerant or intolerant mice. J Surg Res. 1992;52:635.
12. Ayala A, Perrin MM, Meldrum DR, et al. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine. 1990;2:170.
13. Ayala A, Wang P, Ba ZF, et al. Differential alterations in plasma IL-6 and TNF levels following trauma and hemorrhage. Am J Physiol. 1991;260:R167.
14. Pearson JM, Brown AP, Schultze AE, et al. Gadolinium chloride treatment attenuates hepatic platelet accumulation after lipopolysaccharide administration. Shock. 1996;5:408.
15. Gallery M, Kamei T, Flye MW. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990;125:36.
16. Baker CC, Chaudry IH, Gaines HO, et al. Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery. 1983;94:331.
17. Meldrum DR, Ayala A, Perrin MM, et al. Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res. 1991;51:158.
18. Border J. Hypothesis: sepsis, multiple systems organ failure, and the macrophage. Arch Surg. 1988;123:285.
19. Ayala A, Perrin MM, Wang P, et al. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity: involvement of cell-associated TNF and reactive nitrogen. J Immunol. 1991; 147:4147.
20. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA. 1986;83:9679.
21. Espevik T, Nissen-Meyer K. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986;95:99.
22. Mizel SB. Production and quantitation of lymphocyte-activating factor (interleukin 1). In: Herscowitz HB, Holden HT, Bellanti JA, et al., eds. Manual of Macrophage Methodology. New York: Marcel Dekker, Inc.; 1981:407-441.
23. Migliorini P, Corradin G, Corradin SB. Macrophage NO2-production as a sensitive and rapid assay for the quantitation of IFN-gamma. J Immunol Methods. 1991;139:107.
24. Ayala A, Deol ZK, Lehman DL, et al. Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/ IL-10 production. J Surg Res. 1994;56:579.
25. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145.
26. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today. 1996;17:138.
27. Hardonk MJ, Dijkhuis FWJ, Hulstaert CE, et al. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukocyte Biol. 1992;52:296.
28. Ayala A, Deol ZK, Lehman DL, et al. Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg. 1995; 130:1178.
29. Ayala A, Ertel W, Chaudry IH. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex. Shock. 1996; 5:79.
30. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med. 1995;23:376.
31. Zhou D, Munster A, Winchurch RA. Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. FASEB J. 1991;5:2582.
32. Zhou D, Munster AM, Winchurch RA. Inhibitory effects of interleukin 6 on immunity. Possible implications in burn patients. Arch Surg. 1992;127:65.
33. gammaRI cross-linking stimulation. J Clin Immunol. 1991;11:326.
34. Miller-Graziano CL, Szabo G, Griffey K, et al. Role of elevated monocyte transforming growth factor beta (TGF-beta) production in posttrauma immunosuppression. J Clin Immunol. 1991;11:95.
35. Bankey PE, Williams JG, Guice KS, et al. Interleukin-6 production after thermal injury: evidence for nonmacrophage sources in the lung and liver. Surgery. 1995;118:431.
36. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol. 1996;270:R927.
37. Deitch EA, Xu D, Franko L, et al. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1994;1:141.
38. Ogle C, Zuo L, Mao JX, et al. Differential expression of intestinal and splenic cytokines after parenteral nutrition. Arch Surg. 1995;130:1301.
39. Callery MP, Kamei T, Mangino MJ, et al. Organ interactions in sepsis. Arch Surg. 1991;126:28.